126 related articles for article (PubMed ID: 23204621)
21. Qsar study of some substituted 4-quinolinyl and 9-acridinyl hydrazones as antimalarial agents.
Sahu NK; Sharma M; Mourya V; Kohli DV
Acta Pol Pharm; 2012; 69(6):1153-65. PubMed ID: 23285677
[TBL] [Abstract][Full Text] [Related]
22. First report on exploring structural requirements of 1,2,3,4- tetrahydroacridin-9(10H)-one analogs as antimalarials using multiple QSAR approaches: descriptor-based QSAR, CoMFA-CoMSIA 3DQSAR, HQSAR and G-QSAR approaches.
Ojha PK; Roy K
Comb Chem High Throughput Screen; 2013 Jan; 16(1):7-21. PubMed ID: 23127758
[TBL] [Abstract][Full Text] [Related]
23. The use of minimal topological differences to inspire the design of novel tetrahydroisoquinoline analogues with antimalarial activity.
Ngo Hanna J; Nziko VPN; Ntie-Kang F; Mbah JA; Toze FAA
Heliyon; 2021 May; 7(5):e07032. PubMed ID: 34095565
[TBL] [Abstract][Full Text] [Related]
24. Antiprotozoan lead discovery by aligning dry and wet screening: prediction, synthesis, and biological assay of novel quinoxalinones.
Martins Alho MA; Marrero-Ponce Y; Barigye SJ; Meneses-Marcel A; Machado Tugores Y; Montero-Torres A; Gómez-Barrio A; Nogal JJ; García-Sánchez RN; Vega MC; Rolón M; Martínez-Fernández AR; Escario JA; Pérez-Giménez F; Garcia-Domenech R; Rivera N; Mondragón R; Mondragón M; Ibarra-Velarde F; Lopez-Arencibia A; Martín-Navarro C; Lorenzo-Morales J; Cabrera-Serra MG; Piñero J; Tytgat J; Chicharro R; Arán VJ
Bioorg Med Chem; 2014 Mar; 22(5):1568-85. PubMed ID: 24513185
[TBL] [Abstract][Full Text] [Related]
25. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
Mandal AS; Roy K
Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
[TBL] [Abstract][Full Text] [Related]
26. DFT-based reactivity and combined QSAR, molecular docking of 1,2,4,5-Tetrazine derivatives as inhibitors of Pim-1 kinase.
Hazhazi H; Melkemi N; Salah T; Bouachrine M
Heliyon; 2019 Sep; 5(9):e02451. PubMed ID: 31687555
[TBL] [Abstract][Full Text] [Related]
27. QSAR models for antioxidant activity of new coumarin derivatives.
Erzincan P; Saçan MT; Yüce-Dursun B; Danış Ö; Demir S; Erdem SS; Ogan A
SAR QSAR Environ Res; 2015; 26(7-9):721-37. PubMed ID: 26470736
[TBL] [Abstract][Full Text] [Related]
28. 3D-QSAR, docking and ADMET properties of aurone analogues as antimalarial agents.
Hadni H; Elhallaoui M
Heliyon; 2020 Apr; 6(4):e03580. PubMed ID: 32322700
[TBL] [Abstract][Full Text] [Related]
29. Modeling antimalarial activity: application of Kinetic Energy Density Quantum Similarity Measures as descriptors in QSAR.
Gironés X; Gallegos A; Carbó-Dorca R
J Chem Inf Comput Sci; 2000; 40(6):1400-7. PubMed ID: 11128098
[TBL] [Abstract][Full Text] [Related]
30. Role of 2-Dimensional Autocorrelation Descriptors in Predicting Antimalarial Activity of Artemisinin and its Aanalogues: A QSAR Study.
Kalra S; Joshi G; Kumar R; Munshi A
Curr Top Med Chem; 2018; 18(31):2720-2730. PubMed ID: 30659538
[TBL] [Abstract][Full Text] [Related]
31. Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies.
Pingaew R; Prachayasittikul V; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2015 Oct; 103():446-59. PubMed ID: 26397393
[TBL] [Abstract][Full Text] [Related]
32. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
Kumari M; Chandra S; Tiwari N; Subbarao N
BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
[TBL] [Abstract][Full Text] [Related]
33. A study on antimalarial artemisinin derivatives using MEP maps and multivariate QSAR.
Cardoso FJ; de Figueiredo AF; da Silva Lobato M; de Miranda RM; de Almeida RC; Pinheiro JC
J Mol Model; 2008 Jan; 14(1):39-48. PubMed ID: 17968600
[TBL] [Abstract][Full Text] [Related]
34. Investigations on Anticancer and Antimalarial Activities of Indole-Sulfonamide Derivatives and
Pingaew R; Mandi P; Prachayasittikul V; Thongnum A; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
ACS Omega; 2021 Nov; 6(47):31854-31868. PubMed ID: 34870008
[TBL] [Abstract][Full Text] [Related]
35. Developing Enhanced Blood-Brain Barrier Permeability Models: Integrating External Bio-Assay Data in QSAR Modeling.
Wang W; Kim MT; Sedykh A; Zhu H
Pharm Res; 2015 Sep; 32(9):3055-65. PubMed ID: 25862462
[TBL] [Abstract][Full Text] [Related]
36. Quantitative structure-activity relationship to predict the anti-malarial activity in a set of new imidazolopiperazines based on artificial neural networks.
Yousefinejad S; Mahboubifar M; Eskandari R
Malar J; 2019 Sep; 18(1):310. PubMed ID: 31521174
[TBL] [Abstract][Full Text] [Related]
37. QSAR modeling for the antimalarial activity of 1,4-naphthoquinonyl derivatives as potential antimalarial agents.
Luan F; Xu X; Cordeiro MN; Liu H; Zhang X
Curr Comput Aided Drug Des; 2013 Mar; 9(1):95-107. PubMed ID: 23157413
[TBL] [Abstract][Full Text] [Related]
38. Exploration of important sites of antimalarial Endochins for optimum structural modification using group-based QSAR (G-QSAR) modeling.
Ojha PK; Roy K
Curr Comput Aided Drug Des; 2013 Sep; 9(3):336-49. PubMed ID: 24010932
[TBL] [Abstract][Full Text] [Related]
39. Design and prediction of novel pyrazole derivatives as potential anti-cancer compounds based on 2D-2D-QSAR study against PC-3, B16F10, K562, MDA-MB-231, A2780, ACHN and NUGC cancer cell lines.
Bennani FE; Doudach L; Karrouchi K; El Rhayam Y; Rudd CE; Ansar M; El Abbes Faouzi M
Heliyon; 2022 Aug; 8(8):e10003. PubMed ID: 35965973
[TBL] [Abstract][Full Text] [Related]
40. In-silico combinatorial design and pharmacophore modeling of potent antimalarial 4-anilinoquinolines utilizing QSAR and computed descriptors.
Parihar N; Nandi S
Springerplus; 2015; 4(1):819. PubMed ID: 29021931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
